» Articles » PMID: 27247565

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay Between Diet, Gut Microbiota, and Genetic Background

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2016 Jun 2
PMID 27247565
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to steatohepatitis, fibrosis, cirrhosis, and liver cancer. While the pathogenesis of NAFLD remains incompletely understood, a multihit model has been proposed that accommodates causal factors from a variety of sources, including intestinal and adipose proinflammatory stimuli acting on the liver simultaneously. Prior cellular and molecular studies of patient and animal models have characterized several common pathogenic mechanisms of NAFLD, including proinflammation cytokines, lipotoxicity, oxidative stress, and endoplasmic reticulum stress. In recent years, gut microbiota has gained much attention, and dysbiosis is recognized as a crucial factor in NAFLD. Moreover, several genetic variants have been identified through genome-wide association studies, particularly rs738409 (Ile748Met) in PNPLA3 and rs58542926 (Glu167Lys) in TM6SF2, which are critical risk alleles of the disease. Although a high-fat diet and inactive lifestyles are typical risk factors for NAFLD, the interplay between diet, gut microbiota, and genetic background is believed to be more important in the development and progression of NAFLD. This review summarizes the common pathogenic mechanisms, the gut microbiota relevant mechanisms, and the major genetic variants leading to NAFLD and its progression.

Citing Articles

Relationship between dietary inflammatory index and metabolic dysfunction associated steatotic liver disease in children.

Amiri F, Moludi J, Jouybari T, Qasemi M, Sharifi M, Mahaki B Sci Rep. 2025; 15(1):5081.

PMID: 39934274 PMC: 11814066. DOI: 10.1038/s41598-025-89690-x.


The associations between diet-induced inflammation and the improvement or worsening of hepatic steatosis and fibrosis: a longitudinal analysis of RaNCD cohort study.

Sedighi M, Saber A, Bagheri A, Hazratian S, Pasdar Y, Najafi F Nutr Metab (Lond). 2025; 22(1):5.

PMID: 39833863 PMC: 11749311. DOI: 10.1186/s12986-025-00897-1.


Assessing clenbuterol's modulation of metabolic and inflammatory pathways in Nile tilapia (Oreochromas niloticous) fed high fat diet.

Rashwan A, Assar D, Salah A, Abualreesh M, Salem S, Althobaiti N Sci Rep. 2025; 15(1):1581.

PMID: 39794453 PMC: 11724019. DOI: 10.1038/s41598-024-84814-1.


Hepatobiliary and pancreatic manifestations in inflammatory bowel disease: an umbrella review of meta-analyses.

Hong R, Li Z, Li M, Dai Y Therap Adv Gastroenterol. 2025; 18():17562848241311165.

PMID: 39777137 PMC: 11705336. DOI: 10.1177/17562848241311165.


Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.

Luo T, Che Q, Guo Z, Song T, Zhao J, Xu D Front Pharmacol. 2024; 15:1442854.

PMID: 39444598 PMC: 11497133. DOI: 10.3389/fphar.2024.1442854.


References
1.
Yuan J, Baker S, Liu W, Alkhouri R, Baker R, Xie J . Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2013; 29(6):1292-8. DOI: 10.1111/jgh.12510. View

2.
Musso G, Cassader M, Cohney S, Pinach S, Saba F, Gambino R . Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. Trends Mol Med. 2015; 21(10):645-662. DOI: 10.1016/j.molmed.2015.08.005. View

3.
Simonen P, Kotronen A, Hallikainen M, Sevastianova K, Makkonen J, Hakkarainen A . Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. J Hepatol. 2010; 54(1):153-9. DOI: 10.1016/j.jhep.2010.05.037. View

4.
Jiang Y, Zhao M, An W . Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. J Mol Med (Berl). 2011; 89(12):1207-17. DOI: 10.1007/s00109-011-0790-y. View

5.
Mager D, Patterson C, So S, Rogenstein C, Wykes L, Roberts E . Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr. 2010; 64(6):628-35. DOI: 10.1038/ejcn.2010.35. View